XML 31 R16.htm IDEA: XBRL DOCUMENT v3.22.2.2

Organization, Basis of Presentation and Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2022

Accounting Policies [Abstract]

Schedule of Fair Value And Amortized Cost of Marketable Securities

The fair value and amortized cost of marketable securities by major security type is as follows:

		September 30, 2022
(in thousands)		Amortized Cost				Unrealized Gains				Unrealized Losses				Fair Value
Money market funds		$	37,094			$	—			$	—			$	37,094
U.S. government securities			43,120				—				(681	)			42,439
Non-U.S. government securities			3,022				—				(41	)			2,981
Corporate debt securities			29,514				—				(284	)			29,230
Commercial paper			49,659				—				—				49,659
Total		$	162,409			$	—			$	(1,006	)		$	161,403
Classified as:
Cash equivalents														$	37,094
Marketable securities															124,309
Total														$	161,403
		December 31, 2021
(in thousands)		Amortized Cost				Unrealized Gains				Unrealized Losses				Fair Value
Money market funds		$	33,239			$	—			$	—			$	33,239
U.S. government securities			36,322				—				(130	)			36,192
Non-U.S. government securities			11,194				—				(12	)			11,182
Corporate debt securities			39,495				—				(52	)			39,443
Commercial paper			31,466				—				—				31,466
Total		$	151,716			$	—			$	(194	)		$	151,522
Classified as:
Cash equivalents														$	33,239
Marketable securities															118,283
Total														$	151,522

Schedule of Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities included the following:

(in thousands)		September 30, 2022				December 31, 2021
Research and development costs		$	1,559			$	1,570
Compensation and benefit costs			1,993				2,403
Accrued professional fees			862				363
Other			308				358
Total accrued expenses and other current liabilities		$	4,722			$	4,694

Schedule of Antidilutive Securities Excluded from Computation of Net Loss per Share

The Company excluded the following potential shares of common stock, presented based on amounts outstanding at each period end, from the computation of diluted net loss attributable to common stockholders per share of common stock for the periods indicated because including them would have had an anti-dilutive effect:

		September 30,
		2022				2021
Options to purchase common stock			4,760,085				3,556,043
Unvested restricted stock units			100,880				—
Shares issuable under employee stock purchase plan			112,757				—
Total			4,973,722				3,556,043

X

- References

No definition available.

+ Details

Name:	us-gaap_AccountingPoliciesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

+ Details

Name:	us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration